1. Home
  2. AIRG vs NSRX Comparison

AIRG vs NSRX Comparison

Compare AIRG & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airgain Inc.

AIRG

Airgain Inc.

HOLD

Current Price

$4.16

Market Cap

47.4M

Sector

Technology

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$4.86

Market Cap

53.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIRG
NSRX
Founded
1995
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.4M
53.5M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
AIRG
NSRX
Price
$4.16
$4.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$6.25
$20.50
AVG Volume (30 Days)
45.1K
3.5K
Earning Date
05-26-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
31.65
N/A
EPS
N/A
N/A
Revenue
$51,779,000.00
N/A
Revenue This Year
$13.17
N/A
Revenue Next Year
$17.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.00
$3.99
52 Week High
$5.85
$9.99

Technical Indicators

Market Signals
Indicator
AIRG
NSRX
Relative Strength Index (RSI) 36.71 41.33
Support Level $3.96 N/A
Resistance Level $4.36 $6.39
Average True Range (ATR) 0.33 0.70
MACD -0.14 0.01
Stochastic Oscillator 7.41 35.08

Price Performance

Historical Comparison
AIRG
NSRX

About AIRG Airgain Inc.

Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: